Abstract:Induction of pluripotent stem cells from somatic cells by defined factors was shown to be possible only recently, but already several laboratories have made tremendous strive toward improving and understanding the process. Originally, Oct4, Sox2, Klf4, and cMyc were identified as being the combination of genes necessary to induce reprogramming. It was later shown that cMyc was dispensable; however, in its absence the process was less efficient and took a considerably longer period of time to occur. Furthermore, others have shown that the combination of Oct4, Sox2, Nanog, and Lin28 could also induce reprogramming. One major caveat associated with these techniques remains the need for overexpression of several genes using viral systems. Until very recently, most studies were done using integrating viruses such as retroviruses and lentiviruses. This method ensured that the protein of interested would be expressed at a high concentration and for an adequate period of time necessary to induce reprogramming. Up to date, others have now been able to use different nonintegrative method such as adenovirus and plasmid transfection to induce reprogramming. Furthermore, piggyBac transposition was successfully used to induce reprogramming of murine cells. Most importantly, it was recently published that reprogramming can be induced in the absence of virus, with proteins and small molecules. All of the later methods are appealing since they do not require the integration of the virus or plasmid to exert its effect. However, one avenue that would be all the more therapeutically appealing would be to induce reprogramming in the absence of gene overexpression systems, using small molecules to modulate signaling pathways in the somatic cells. A few molecules have already been identified with the ability to either improve the process or replace one or two of the genes deemed necessary for reprogramming. We have screened successfully for compounds that can replace some of these factors, and share the methods developed following these screens.

Generation of pluripotent stem cells without the use of genetic material

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells

Generation of Transgene-free Induced Pluripotent Stem Cells with Non-viral Methods

Evolution of Induced Pluripotent Stem Cell Technology

Chemically Induced Pluripotent Stem Cells (cipscs): a Transgene-Free Approach.

Experimental approaches for the generation of induced pluripotent stem cells

Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells

Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development

An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells

Progress in the Reprogramming of Somatic Cells

Nanotechnology in Generation and Biomedical Application of Induced Pluripotent Stem Cells

Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules

Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming

A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors

Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery Behind Reprogramming

Inducing Pluripotency in Somatic Cells: Historical Perspective and Recent Advances

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells